Nevertheless, it should be noted that the inhibition of NOTCH1 by γ-secretase inhibitor treatment or by siRNAs also significantly promoted both ERBB3 expression and lung cancer cell growth in the absence of gefitinib (Figs 3, 4, 5, 6). This evidence concerns the gene NOTCH1 and lung carcinoma.